Iberia Pharmaceuticals India Limited - Company Profile

It is a trading public limited company based in New Delhi, Delhi, India, established in 2013.

2013 New Delhi, Delhi, India Active

Last Updated: January 06, 2026

About Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited, a active public limited company, was established on 30 March 2013 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U24232DL2013PLC250040. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹1.77 M.

Formerly known as Satnam Medical Agencies Private Limited, Iberia Pharmaceuticals India Limited. It upholds a compliant status. Employing 140 professional, Its leadership includes Rishab Jain (Whole-Time Director), Nitin Jain (Managing Director), Harmeet Kaur (Director). Past directors included Rishab Jain, Nitin Jain, Praveen Jain. It holds ₹10.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Property No. 4, Block-C, First Floor, Sector-8, Dwarka, New Delhi, Delhi, 110077.

Company Details

CIN/LLPIN
U24232DL2013PLC250040
Registration Number
250040
Incorporation Date
30 March 2013
Authorized Capital
₹30.00 Cr
Paid-Up Capital
₹1.77 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 30.00 Cr as on 06-01-2026
Paid Up Capital ₹ 1.77 M as on 06-01-2026
Company Age 12 Year, 10 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 10.25 Cr as on 06-01-2026
Revenue Growth **** 53.87% (FY 2023)
Profit Growth **** 361.04% (FY 2023)
Ebitda **** 211.03% (FY 2023)
Net Worth 125.94% (FY 2023)
Total Assets **** 36.73% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Iberia Pharmaceuticals India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Iberia Pharmaceuticals India Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rishab Jain	Whole-Time Director	02 May 2021	Current
Nitin Jain	Managing Director	30 Mar 2013	Current
Harmeet Kaur	Director	01 Mar 2025	Current
Atul Bhola	Director	01 Mar 2025	Current
Aditya Rungta	Director	01 Mar 2025	Current
Saurav Ojha	Whole-Time Director	30 Sep 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	20 Apr 2017	Past
Pramod Abcsdd	Director	28 Feb 2025	Past
Pramod Abcsdd	Director	02 May 2021	Past
Pramod Abcsdd	Director	28 Feb 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Iberia Pharmaceuticals India.

Iberia Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.87% increase. The company also saw a substantial improvement in profitability, with a 361.04% increase in profit. The company's net worth Soared by an impressive increase of 125.94%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

53.87%

*******

Revenue from Operations

*******

52.09%

*******

Total Assets

*******

36.73%

*******

Profit or Loss

*******

361.04%

*******

Net Worth

*******

125.94%

*******

EBITDA

*******

211.03%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Iberia Pharmaceuticals India?

In 2023, Iberia Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹102,508,998.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Others : 10.00 Cr
Hdfc Bank Limited : 0.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Dec 2023	Others	₹10.00 Cr	Open
27 Dec 2023	Hdfc Bank Limited	₹2.51 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Iberia Pharmaceuticals India?

Unlock and access historical data on people associated with Iberia Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Iberia Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iberia Pharmaceuticals India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Iberia Pharmaceuticals India

Recent Activity within the Organization

Director Appointment

The activity Shripati Sharma was appointed as a Cfo was appointed as a Cfo on 15 Oct 2025 & has been associated with this company since 4 months 5 days . was completed.
15 Oct 2025
Charges

A charge with Others of Rs. 10.00 Cr registered on 27 Dec 2023 with Charge ID 100850475 was modified on 06 Aug 2025. was recorded as a recent event.
06 Aug 2025
Director Appointment

The activity Deepanshu was appointed as a Cfo was appointed as a Cfo on 01 Apr 2025 & has been associated with this company since 10 months 18 days . was completed.
01 Apr 2025
Director Appointment

Progress on Harmeet Kaur was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 11 months 19 days . was documented.
01 Mar 2025
Director Appointment

Atul Bhola was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 11 months 19 days . was recorded as a recent event.
01 Mar 2025
Director Appointment

Aditya Rungta was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 11 months 19 days . was recorded as a recent event.
01 Mar 2025

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Iberia Pharmaceuticals India Limited?

The CIN of Iberia Pharmaceuticals India Limited is U24232DL2013PLC250040.

Where is Iberia Pharmaceuticals India Limited headquartered?

Iberia Pharmaceuticals India Limited is headquartered at Property No. 4, Block-C, First Floor, Sector-8, Dwarka, New Delhi, Delhi, 110077.

When was Iberia Pharmaceuticals India Limited incorporated?

Iberia Pharmaceuticals India Limited was incorporated on 30 March 2013.

Who are the current directors of Iberia Pharmaceuticals India Limited?

The current directors of Iberia Pharmaceuticals India Limited are

What is the primary industry of Iberia Pharmaceuticals India Limited?

The primary industry of Iberia Pharmaceuticals India Limited is Trade.

Is Iberia Pharmaceuticals India Limited a listed company?

Iberia Pharmaceuticals India Limited is unlisted.

What is the capital structure of Iberia Pharmaceuticals India Limited?

The authorized capital of Iberia Pharmaceuticals India Limited is ₹30.00 Cr, and the paid-up capital is ₹1.77 M.

What is the compliance status of Iberia Pharmaceuticals India Limited?

The compliance status of Iberia Pharmaceuticals India Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available